Public hospitalizations for stroke in Brazil from 2009 to 2016.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 09 07 2018
accepted: 01 03 2019
entrez: 20 3 2019
pubmed: 20 3 2019
medline: 18 12 2019
Statut: epublish

Résumé

Stroke is the third major cause of death in the world and the second in Brazil. The purpose of this work was to assess the stroke-related hospitalization, in-hospital mortality, and case fatality rates under the Brazilian Unified Health System (SUS) from 2009 to 2016. We evaluated the hospital admissions for stroke and their associated outcomes using data from the Hospital Information available at the Informatics Department of SUS. We selected hospitalization registries according to stroke diagnosis codes from the International Statistical Classification of Diseases and Related Health Problems (ICD-10). We identified the association of age and sex with patient death through multiple logistic regression and calculated the rates of hospitalization, mortality and case-fatality per 100,000 inhabitants using age-adjustment methodology. We analyzed 1,113,599 stroke hospitalizations. From 2009 to 2016, the number of admissions increased from 131,122 to 146,950 and the absolute number of in-hospital deaths increased from 28,731 to 31,937. Younger age and male sex were significantly associated with patient survival. Our results showed that the annual age-adjusted hospitalization and in-hospital mortality rates decreased by 11.8% and 12.6%, respectively, but the case fatality rate increased for patients older than 70 years. Although the age-adjusted hospitalization and in-hospital mortality rates declined, the total number of hospitalization and deaths have increased. It is expected a continuous increase over the next years of stroke admissions with the rapid aging of the Brazilian population. Efforts should be renewed targeting risk factors, access to hospital and rehabilitation in particular for the elderly population.

Sections du résumé

BACKGROUND
Stroke is the third major cause of death in the world and the second in Brazil. The purpose of this work was to assess the stroke-related hospitalization, in-hospital mortality, and case fatality rates under the Brazilian Unified Health System (SUS) from 2009 to 2016.
METHODS
We evaluated the hospital admissions for stroke and their associated outcomes using data from the Hospital Information available at the Informatics Department of SUS. We selected hospitalization registries according to stroke diagnosis codes from the International Statistical Classification of Diseases and Related Health Problems (ICD-10). We identified the association of age and sex with patient death through multiple logistic regression and calculated the rates of hospitalization, mortality and case-fatality per 100,000 inhabitants using age-adjustment methodology.
RESULTS
We analyzed 1,113,599 stroke hospitalizations. From 2009 to 2016, the number of admissions increased from 131,122 to 146,950 and the absolute number of in-hospital deaths increased from 28,731 to 31,937. Younger age and male sex were significantly associated with patient survival. Our results showed that the annual age-adjusted hospitalization and in-hospital mortality rates decreased by 11.8% and 12.6%, respectively, but the case fatality rate increased for patients older than 70 years.
CONCLUSIONS
Although the age-adjusted hospitalization and in-hospital mortality rates declined, the total number of hospitalization and deaths have increased. It is expected a continuous increase over the next years of stroke admissions with the rapid aging of the Brazilian population. Efforts should be renewed targeting risk factors, access to hospital and rehabilitation in particular for the elderly population.

Identifiants

pubmed: 30889198
doi: 10.1371/journal.pone.0213837
pii: PONE-D-18-20276
pmc: PMC6424448
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0213837

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Arq Neuropsiquiatr. 2007 Sep;65(3B):752-7
pubmed: 17952275
Arq Bras Cardiol. 2016 Aug;107(2):137-46
pubmed: 27437866
Lancet. 2018 Sep 1;392(10149):760-775
pubmed: 30037735
Cad Saude Publica. 2011 Nov;27(11):2106-16
pubmed: 22124488
N Engl J Med. 2018 Dec 20;379(25):2429-2437
pubmed: 30575491
Stroke. 2007 Nov;38(11):2906-11
pubmed: 17916767
Lancet. 2016 Aug 20;388(10046):761-75
pubmed: 27431356
J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):749-54
pubmed: 19147630
PLoS One. 2016 Jun 22;11(6):e0152739
pubmed: 27332892
Sao Paulo Med J. 2015 Nov-Dec;133(6):457-9
pubmed: 26760122
Int J Stroke. 2014 Jan;9(1):6-18
pubmed: 24350870
Presse Med. 2016 Dec;45(12 Pt 2):e391-e398
pubmed: 27816343
BMJ Glob Health. 2018 Jul 3;3(4):e000829
pubmed: 29997906
Rev Neurol (Paris). 2016 Jan;172(1):59-68
pubmed: 26718592
Arq Bras Cardiol. 2012 Jun;98(6):519-27
pubmed: 22534777
Arq Neuropsiquiatr. 2016 May;74(5):376-81
pubmed: 27191233
Diabetol Metab Syndr. 2016 Oct 13;8:70
pubmed: 27757172
J Neurol Sci. 2015 Oct 15;357(1-2):240-5
pubmed: 26293417
PLoS One. 2012;7(10):e48255
pubmed: 23118964
Stroke. 2011 Dec;42(12):3341-6
pubmed: 22052521
Lancet. 2014 Jan 18;383(9913):245-54
pubmed: 24449944
Lancet. 2017 Feb 11;389(10069):641-654
pubmed: 27637676
Stroke. 2014 Jan;45(1):315-53
pubmed: 24309587
BMC Res Notes. 2018 Oct 16;11(1):735
pubmed: 30326942
Int J Stroke. 2010 Aug;5(4):284-9
pubmed: 20636711
Can J Neurol Sci. 2015 May;42(3):168-75
pubmed: 25857318

Auteurs

Leila F Dantas (LF)

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Janaina F Marchesi (JF)

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Igor T Peres (IT)

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Silvio Hamacher (S)

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Fernando A Bozza (FA)

Evandro Chagas National Institute of Infectious Disease, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
IDOR, D'Or Institute for Research and Education, Rio de Janeiro, RJ, Brazil.

Ricardo A Quintano Neira (RA)

Department of Industrial Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH